1.34
price down icon2.90%   -0.04
after-market Handel nachbörslich: 1.34
loading
Schlusskurs vom Vortag:
$1.38
Offen:
$1.36
24-Stunden-Volumen:
38,935
Relative Volume:
0.32
Marktkapitalisierung:
$20.74M
Einnahmen:
$321.50K
Nettoeinkommen (Verlust:
$-7.24M
KGV:
-0.7658
EPS:
-1.7498
Netto-Cashflow:
$-5.72M
1W Leistung:
+3.08%
1M Leistung:
-26.37%
6M Leistung:
-35.89%
1J Leistung:
-5.13%
1-Tages-Spanne:
Value
$1.32
$1.40
1-Wochen-Bereich:
Value
$1.3001
$1.43
52-Wochen-Spanne:
Value
$1.25
$3.62

Bioaffinity Technologies Inc Stock (BIAF) Company Profile

Name
Firmenname
Bioaffinity Technologies Inc
Name
Telefon
210-698-5334
Name
Adresse
22211 WEST INTERSTATE-10, SAN ANTONIO
Name
Mitarbeiter
75
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
BIAF's Discussions on Twitter

Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten

pulisher
04:22 AM

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development - Zenopa

04:22 AM
pulisher
Nov 04, 2024

BioAffinity Technologies appoints William Bauta, Ph.D. Chief Science Officer - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

bioAffinity appoints new Chief Science Officer By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Oct 31, 2024

J. Michael Edwards Named CFO at bioAffinity Technologies - MPO-mag

Oct 31, 2024
pulisher
Oct 31, 2024

SA company sets the stage for Asian expansion - The Business Journals

Oct 31, 2024
pulisher
Oct 31, 2024

bioAffinity’s CyPath Lung Test Now Available to U.S. Veterans - MPO-mag

Oct 31, 2024
pulisher
Oct 31, 2024

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung - Zenopa

Oct 31, 2024
pulisher
Oct 30, 2024

bioAffinity secures Japanese patent for lung health test By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

BIAFbioAffinity Technologies, Inc. Latest Stock News & Market Updates - StockTitan

Oct 30, 2024
pulisher
Oct 30, 2024

bioAffinity secures Japanese patent for lung health test - Investing.com

Oct 30, 2024
pulisher
Oct 21, 2024

bioAffinity Technologies Closes of $2.6 Million Registered Direct Offering & Concurrent Private Placement - citybiz

Oct 21, 2024
pulisher
Oct 21, 2024

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement - StockTitan

Oct 21, 2024
pulisher
Oct 21, 2024

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement - StockTitan

Oct 21, 2024
pulisher
Oct 21, 2024

SEC Form 424B5 filed by bioAffinity Technologies Inc. - Quantisnow

Oct 21, 2024
pulisher
Oct 18, 2024

WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement - StockTitan

Oct 18, 2024
pulisher
Oct 18, 2024

bioAffinity Technologies Prices of $2.66 Million Registered Direct Offering & Concurrent Private Placement - citybiz

Oct 18, 2024
pulisher
Oct 18, 2024

BioAffinity Technologies Down 25% on Stock Sale, Warrant Private Placement - MarketWatch

Oct 18, 2024
pulisher
Oct 18, 2024

bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement - StockTitan

Oct 18, 2024
pulisher
Oct 16, 2024

bioAffinity VP contributes to new cytometry guidelines - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

bioAffinity VP contributes to new cytometry guidelines By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines - StockTitan

Oct 16, 2024
pulisher
Oct 12, 2024

Lung cancer test speeds growth of San Antonio's bioAffinity - Head Topics

Oct 12, 2024
pulisher
Oct 12, 2024

New lung cancer test uses phlegm, machine learning to make early diagnoses - San Antonio Express-News

Oct 12, 2024
pulisher
Oct 11, 2024

SA biomed to expand military market under new CFO - The Business Journals

Oct 11, 2024
pulisher
Oct 11, 2024

bioAffinity Technologies names J. Michael Edwards as CFO - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

bioAffinity Technologies names J. Michael Edwards as CFO By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 10, 2024

bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer - citybiz

Oct 10, 2024
pulisher
Oct 10, 2024

bioAffinity Technologies Welcomes Back CFO for Future Growth - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

bioAffinity Technologies Appoints J. Michael Edwards as Chief Financial Officer - TechBullion

Oct 10, 2024
pulisher
Oct 10, 2024

bioAffinity Technologies makes phlegm lung cancer test widely available to Veterans - Mugglehead

Oct 10, 2024
pulisher
Oct 09, 2024

Maxim Group Initiates Coverage of bioAffinity Technologies (BIAF) with Buy Recommendation - MSN

Oct 09, 2024
pulisher
Oct 09, 2024

BioAffinity Technologies : Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test Form 8 K - Marketscreener.com

Oct 09, 2024
pulisher
Oct 09, 2024

bioAffinity Technologies Expands Access to Lung Cancer Test - TipRanks

Oct 09, 2024
pulisher
Oct 09, 2024

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test - StockTitan

Oct 09, 2024
pulisher
Oct 08, 2024

bioAffinity Technologies secures shareholder nod for warrant exercise - Investing.com

Oct 08, 2024
pulisher
Oct 07, 2024

bioAffinity Technologies secures shareholder nod for warrant exercise By Investing.com - Investing.com UK

Oct 07, 2024
pulisher
Sep 24, 2024

bioAffinity Technologies (NASDAQ:BIAFW) Shares Up 9.3% - Defense World

Sep 24, 2024
pulisher
Sep 18, 2024

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis - BioSpace

Sep 18, 2024
pulisher
Sep 16, 2024

BioAffinity Technologies Searching For New Finance Chief - MPO-mag

Sep 16, 2024
pulisher
Sep 16, 2024

bioAffinity Technologies Searching for New Finance Chief - MPO-mag

Sep 16, 2024
pulisher
Sep 14, 2024

bioAffinity Technologies announces secondary offering of 1.8M shares - MSN

Sep 14, 2024
pulisher
Sep 02, 2024

Ratios Reveal: Breaking Down BioAffinity Technologies Inc (BIAF)’s Financial Health - The Dwinnex

Sep 02, 2024
pulisher
Aug 23, 2024

bioAffinity Technologies Announces CFO Transition and Appointment - TipRanks

Aug 23, 2024
pulisher
Aug 23, 2024

BioAffinity Names Michael Edwards as Interim CFO - MarketWatch

Aug 23, 2024
pulisher
Aug 23, 2024

bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO - Business Wire

Aug 23, 2024
pulisher
Aug 21, 2024

bioAffinity Technologies (NASDAQ:BIAFW) Stock Price Up 7% - Defense World

Aug 21, 2024
pulisher
Aug 15, 2024

Earnings roundup: Biglari hurt by investments; BioAffinity gains momentum - San Antonio Express-News

Aug 15, 2024
pulisher
Aug 14, 2024

BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q2 2024 - InvestorPlace

Aug 14, 2024
pulisher
Aug 14, 2024

SEC Form 424B3 filed by bioAffinity Technologies Inc. - Quantisnow

Aug 14, 2024
pulisher
Aug 14, 2024

bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales - Manchestertimes

Aug 14, 2024
pulisher
Aug 11, 2024

BioAffinity Technologies, Inc. announced that it has received $1.302084 million in funding - Marketscreener.com

Aug 11, 2024

Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$226.42
price up icon 3.48%
diagnostics_research LH
$229.11
price up icon 0.85%
diagnostics_research WAT
$387.17
price down icon 0.04%
$154.96
price up icon 0.96%
diagnostics_research MTD
$1,385.79
price up icon 1.60%
$415.98
price up icon 0.35%
Kapitalisierung:     |  Volumen (24h):